$11.98 WBA Walgreens Boots Alliance NASDAQ 03 Feb 2026 pre-market: volume spike

WBA stock trades pre-market at $11.98, drawing heavy activity with 452,081,061 shares changing hands. Market participants are watching Walgreens Boots Alliance, Inc. (WBA) on NASDAQ in the United States after a sharp volume spike versus average volume 16,940,296.00. The price sits between the year high $13.25 and low $8.08, and key metrics show EPS -7.29 and PE -1.64, tying recent trading to company fundamentals and short-interest updates.

WBA stock market snapshot

Pre-market price is $11.98 on NASDAQ in the United States. Volume is 452,081,061, versus an average volume of 16,940,296.00, producing a relative volume of 26.69. Market cap is $10,369,421,068.00 and shares outstanding are 865,561,024.00.

Why WBA is most active pre-market

The spike reflects institutional flows and short-interest scrutiny reported by MarketBeat. Heightened trading follows data on ownership and short volume, which can amplify moves before the bell. MarketBeat short interest and volume data shows recent hedge fund activity as a likely catalyst.

Fundamentals and valuation for WBA stock

Walgreens Boots Alliance shows EPS -7.29 and PE -1.64, reflecting multi-year losses. Price-to-book is 1.44 and price-to-sales is 0.07. Debt-to-equity runs at 4.04, and current ratio is 0.60, signaling balance-sheet leverage. Revenue per share is 178.73 and free cash flow per share is 0.67, indicating cash generation but tight margins.

Technicals and intraday trading cues for WBA

Key technical reads show price above the 50-day average $11.66 and 200-day average $10.81. Keltner channel middle sits at 11.93, supporting the current trade. On short horizons, watch the gap between $11.98 and near resistance $13.25 for profit-taking or continuation.

Meyka AI grade and model forecast

Meyka AI rates WBA with a score out of 100: 57.96 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects $4.08 (yearly model projection) versus the current price $11.98, an implied downside of -65.96%. Forecasts are model-based projections and not guarantees. For ownership flows and filings, see MarketBeat institutional ownership reporting source.

Price targets, risks and sector context

Analyst-style scenario targets: conservative $9.00, base $12.50, bull $15.00. Risks include high leverage, negative EPS, and margin pressure. Opportunities include retail footprint optimization and specialty pharmacy growth. The Healthcare sector trade shows mixed performance, making relative sector moves important for WBA stock trading.

Final Thoughts

WBA stock trades pre-market at $11.98 on NASDAQ with an outsized volume surge of 452,081,061 shares. Short-interest attention and institutional flows explain much of today’s activity. Fundamentals show EPS -7.29, PE -1.64, price-to-book 1.44, and debt-to-equity 4.04, highlighting leverage and recovery risk. Meyka AI rates WBA C+ (57.96) and projects $4.08 on its yearly model, implying -65.96% versus the current price. That model view contrasts with scenario targets ranging $9.00 to $15.00, reflecting divergent assumptions. Traders focused on most-active names should use tight risk controls given volatility, large pre-market volume, and mixed fundamental signals. Meyka AI provides this as an AI-powered market analysis platform detail. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.